Quick Answer
BIOVIE INC. reported Net Income Loss of -$17.54 million for the year ending 2025.
- BIOVIE INC. showed an increase of +45.4% in Net Income Loss from 2024 to 2025.
- This data is from BIOVIE INC.'s annual report (Form 10-K), filed with the SEC on August 15, 2025.
- XBRL data for this metric is available from 2013 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: -$58.8 thousand | Q4 2014: -$70.5 thousand | Q1 2015: -$49.0 thousand | Q3 2015: -$54.6 thousand | Q4 2015: -$49.9 thousand | Q1 2016: -$57.8 thousand | Q3 2016: -$351.3 thousand | Q4 2016: -$357.8 thousand | Q1 2017: -$178.5 thousand | Q3 2017: -$662.8 thousand | Q4 2017: -$502.7 thousand | Q1 2018: -$692.6 thousand | Q3 2019: -$3.82 million | Q4 2019: $6.67 million | Q1 2020: -$366.4 thousand | Q3 2020: $7.33 million | Q4 2020: -$3.06 million | Q1 2021: -$2.99 million | Q3 2021: -$5.54 million | Q4 2021: -$5.41 million | Q1 2022: -$7.04 million | Q3 2022: -$10.42 million | Q4 2022: -$15.69 million | Q1 2023: -$15.04 million | Q3 2023: -$10.71 million | Q4 2023: -$8.40 million | Q1 2024: -$8.07 million | Q3 2024: -$4.15 million | Q4 2024: -$7.11 million | Q1 2025: -$2.79 million | Q3 2025: -$5.09 million | Q4 2025: -$6.07 million.
- Over the full 12 years of available data (2013 to 2025), BIOVIE INC.'s Net Income Loss has declined by 100,083.4%.
- Historical annual values: Fiscal year 2025: -$17.54 million | Fiscal year 2024: -$32.12 million | Fiscal year 2023: -$50.26 million | Fiscal year 2022: -$26.08 million | Fiscal year 2021: -$130.25 million | Fiscal year 2020: -$16.68 million | Fiscal year 2018: -$2.43 million | Fiscal year 2017: -$1.33 million | Fiscal year 2016: -$431.9 thousand | Fiscal year 2015: -$233.0 thousand | Fiscal year 2014: -$321.9 thousand | Fiscal year 2013: -$17.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: